Literature DB >> 28007492

Prostate Biopsy-related Infection: A Systematic Review of Risk Factors, Prevention Strategies, and Management Approaches.

Matthew J Roberts1, Harrison Y Bennett2, Patrick N Harris3, Michael Holmes4, Jeremy Grummet5, Kurt Naber6, Florian M E Wagenlehner7.   

Abstract

A systematic review to identify risk factors for prostate biopsy-related infection, preventative strategies, and optimal management of infectious complications was conducted. Significant risk factors for postbiopsy infection include urogenital infection, antibiotic use, international travel, hospital exposure, bacteriuria, previous transrectal biopsy, and resistance of fecal flora to antibiotic prophylaxis (especially fluoroquinolones). Patients at risk may benefit from an adjusted biopsy protocol comprising transrectal biopsy under targeted prophylaxis, and/or the use of rectal disinfection techniques or using a transperineal approach. Management of biopsy-related infection should be based on individual risk and local resistance profiles with input from multiple specialties.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28007492     DOI： 10.1016/j.urology.2016.12.011

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


  24 in total

Review 1.  [Prudent use of antimicrobial prophylaxis : Prevention of increasing antibiotic resistance].

Authors:  C Hein; A Pilatz; F M E Wagenlehner
Journal:  Urologe A       Date:  2017-09       Impact factor: 0.639

Review 2.  [Fusion biopsies for primary diagnosis of prostate cancer : Implementation, benefits, and clinical aspects].

Authors:  L Püllen; B Hadaschik; D Eberli; T H Kuru
Journal:  Urologe A       Date:  2019-05       Impact factor: 0.639

3.  Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institution.

Authors:  Matthew J Roberts; Alastair Macdonald; Sachinka Ranasinghe; Harrison Bennett; Patrick E Teloken; Patrick Harris; David Paterson; Geoff Coughlin; Nigel Dunglison; Rachel Esler; Robert A Gardiner; Thomas Elliott; Louisa Gordon; John Yaxley
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-08-05       Impact factor: 5.554

4.  Infectious complications of prostate biopsy: winning battles but not war.

Authors:  Okan Derin; Limírio Fonseca; Rafael Sanchez-Salas; Matthew J Roberts
Journal:  World J Urol       Date:  2020-02-24       Impact factor: 4.226

5.  Enhanced antibiotic prophylaxis and infection-related complications following prostate biopsy.

Authors:  Rebecca S Steinberg; Lauren Kipling; K C Biebighauser Bens; Dattatraya Patil; Mark Henry; Akanksha Mehta; Christopher Filson
Journal:  World J Urol       Date:  2021-03-26       Impact factor: 3.661

6.  The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk Calculator.

Authors:  Sneha Parekh; Parita Ratnani; Ugo Falagario; Dara Lundon; Deepshikha Kewlani; Jordan Nasri; Zach Dovey; Dimitrios Stroumbakis; Daniel Ranti; Ralph Grauer; Stanislaw Sobotka; Adriana Pedraza; Vinayak Wagaskar; Lajja Mistry; Ivan Jambor; Anna Lantz; Otto Ettala; Armando Stabile; Pekka Taimen; Hannu J Aronen; Juha Knaapila; Ileana Montoya Perez; Giorgio Gandaglia; Alberto Martini; Wolfgang Picker; Erik Haug; Luigi Cormio; Tobias Nordström; Alberto Briganti; Peter J Boström; Giuseppe Carrieri; Kenneth Haines; Michael A Gorin; Peter Wiklund; Mani Menon; Ash Tewari
Journal:  Eur Urol Open Sci       Date:  2022-05-20

7.  A novel method for pain control: infiltration free local anesthesia technique (INFLATE) for transrectal prostatic biopsy using transcutaneous electrical nerve stimulation (TENS).

Authors:  Mustafa Suat Bolat; Onder Cinar; Ramazan Asci; Recep Buyukalpelli
Journal:  Int Urol Nephrol       Date:  2019-09-06       Impact factor: 2.370

8.  The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis.

Authors:  Susan Scott; Patrick N Harris; Deborah A Williamson; Michael A Liss; Suhail A R Doi; Matthew J Roberts
Journal:  World J Urol       Date:  2018-02-16       Impact factor: 4.226

Review 9.  Rationale and protocol for randomized study of transrectal and transperineal prostate biopsy efficacy and complications (ProBE-PC study).

Authors:  Badar M Mian; Ronald P Kaufman; Hugh A G Fisher
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-03-25       Impact factor: 5.554

10.  Monoprophylaxis With Cephalosporins for Transrectal Prostate Biopsy After the Fluoroquinolone-Era: A Multi-Institutional Comparison of Severe Infectious Complications.

Authors:  Mike Wenzel; Jost von Hardenberg; Maria N Welte; Samuel Doryumu; Benedikt Hoeh; Clarissa Wittler; Thomas Höfner; Maximilian C Kriegmair; Maurice S Michel; Felix Kh Chun; Jonas Herrmann; Philipp Mandel; Niklas Westhoff
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.